Ultragenyx Pharmaceutical Inc.
RARE | NASDAQ
$15.74
+$1.09 (+7.44%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 125M | 175M | 434M | 212.34M | 166.11M | 127.06M | 173.73M | 150.62M | 480.69M | 112.25M | 213.58M | 72.58M | 102.06M | 85.77M | 132.94M | 391.65M | 159.87M | 153.99M | 307.58M | 197.54M | 290.88M | 383.79M |
Short-Term Investments | 167M | 238M | 259M | 222.74M | 311.28M | 367.39M | 436.3M | 470.99M | 283.13M | 299.83M | 363.63M | 369.52M | 449.92M | 543.59M | 614.82M | 497.02M | 382.93M | 444.33M | 432.61M | 539.58M | 554.88M | 581.61M |
Long-Term Investments | 150M | 127M | 59M | 22.07M | 51.45M | 68.56M | 135M | 203.09M | 110.67M | 156.58M | 199.9M | 86.11M | 71.83M | 90.41M | 148.97M | 121.35M | 178.71M | 241.12M | 293.86M | 290.46M | 231.74M | 216.38M |
Other Long-Term Assets | 57M | 55M | 35M | 57.86M | 60.12M | 62.37M | 62.68M | 53.87M | 53.77M | 59.97M | 57.69M | 27.9M | 26.49M | 22.26M | 48.34M | 18.29M | 21.14M | 21.22M | 20.56M | 16.42M | 12.67M | 8.93M |
Receivables | 200M | 121M | 159M | 114.64M | 124.46M | 98.84M | 121.8M | 93.3M | 105.98M | 100.25M | 73.39M | 79.26M | 70.52M | 42.99M | 40.45M | 31.16M | 37.21M | 28.37M | 44.43M | 25.38M | 24.72M | 25.03M |
Inventory | 59M | 55M | 52M | 52.2M | 46.5M | 46.03M | 45.01M | 43.33M | 40.14M | 35.91M | 33.97M | 31.8M | 28.26M | 26.62M | 26.77M | 21.85M | 21.08M | 17.81M | 16.23M | 15.19M | 15.08M | 12.46M |
Other Current Assets | n/a | 68M | 47M | 41.29M | 71.44M | 59.85M | 40.29M | 41.37M | 54.7M | 47.73M | 47.62M | 46.03M | 51.38M | 67.38M | 68.93M | 3.72M | 3.42M | 4.02M | 55.75M | n/a | 13.8M | n/a |
Total Current Assets | 606M | 657M | 951M | 643.21M | 719.79M | 699.16M | 817.12M | 799.61M | 964.64M | 595.97M | 732.18M | 599.19M | 702.14M | 766.34M | 883.9M | 1.01B | 678.54M | 707.52M | 856.6M | 846.88M | 949.49M | 1.07B |
Property-Plant & Equipment | 235M | 239M | 267M | 249.96M | 255.76M | 260.91M | 265.93M | 272.45M | 278.71M | 285.11M | 290.57M | 323.24M | 308.21M | 300.82M | 259.73M | 263.37M | 238.63M | 209.77M | 176.18M | 155.77M | 143.19M | 126.08M |
Goodwill & Intangibles | 216M | 218M | 220M | 217.35M | 219.14M | 220.93M | 222.72M | 209.35M | 210.65M | 209.45M | 210.68M | 201.71M | 202.64M | 203.58M | 204.51M | 202.81M | 203.6M | 204.4M | 175.19M | 175.28M | 175.36M | 175.44M |
Total Long-Term Assets | 658M | 639M | 581M | 547.24M | 586.48M | 612.77M | 686.33M | 738.76M | 653.8M | 711.11M | 758.83M | 638.95M | 609.17M | 617.07M | 661.55M | 605.81M | 642.09M | 676.51M | 665.79M | 637.92M | 562.95M | 526.83M |
Total Assets | 1.26B | 1.3B | 1.53B | 1.19B | 1.31B | 1.31B | 1.5B | 1.54B | 1.62B | 1.31B | 1.49B | 1.24B | 1.31B | 1.38B | 1.55B | 1.62B | 1.32B | 1.38B | 1.52B | 1.48B | 1.51B | 1.6B |
Account Payables | 39M | 42M | 31M | 40.57M | 34.24M | 47.45M | 38.76M | 35.99M | 59.81M | 40.97M | 42.11M | 33.36M | 42.12M | 58.98M | 43.27M | 23.53M | 34.21M | 23.69M | 17.14M | 15.58M | 21.79M | 15.74M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.48M | 2.96M | 4.44M | 5.87M | 7.61M | n/a | 3.91M | 19.22M |
Short-Term Debt | 76M | 72M | 81M | 65.55M | n/a | n/a | n/a | 10.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 15M | 17M | 183M | 1.24M | 114.42M | 100.45M | 87.47M | 155.67M | 74.89M | 42.69M | 46.27M | 29.93M | 23.72M | 3.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 351M | 325M | 384M | 340.02M | 293.24M | 291.67M | 344.15M | 285.01M | 272.87M | 245.58M | 280.44M | 253.98M | 244.38M | 218.18M | 261.21M | 227.36M | 220.64M | 167.23M | 181.37M | 135.93M | 127.07M | 127.04M |
Long-Term Debt | 1.13B | 1.13B | 1.17B | 785.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 41M | 42M | -4M | -2.91M | 800.15M | 811.17M | 836.91M | 845.81M | 857.35M | 863.2M | 874.53M | 886.23M | 891.39M | 895.74M | 880.26M | 866.11M | 362.71M | 359.03M | 352.79M | 348.54M | 344.04M | 340.21M |
Total Long-Term Liabilities | 1.2B | 1.2B | 1.22B | 834.26M | 854.74M | 869.01M | 897.01M | 899.53M | 913.15M | 921.24M | 935.16M | 952.45M | 937.9M | 944.74M | 931.74M | 922.28M | 421.92M | 420.37M | 418.47M | 415.19M | 413.21M | 416.14M |
Total Liabilities | 1.55B | 1.53B | 1.61B | 1.17B | 1.15B | 1.16B | 1.24B | 1.18B | 1.19B | 1.17B | 1.22B | 1.21B | 1.18B | 1.16B | 1.19B | 1.15B | 642.55M | 587.61M | 599.84M | 551.13M | 540.27M | 543.18M |
Total Debt | 1.2B | 1.2B | 1.28B | 884.8M | 36.3M | 38.27M | 40.34M | 34.08M | 37.46M | 40.76M | 43.17M | 46.62M | 25.73M | 28.6M | 31.59M | 34.68M | 37.53M | 39.37M | 41.97M | 44.04M | 46.17M | 46.13M |
Book Value | -284M | -229M | -73M | 16.16M | 158.29M | 151.25M | 262.3M | 353.83M | 432.42M | 140.26M | 275.41M | 31.71M | 129.03M | 220.48M | 352.49M | 468.83M | 678.07M | 796.42M | 922.56M | 933.67M | 972.17M | 1.05B |
Book Value Per Share | -2.79 | -2.28 | -0.73 | 0.16 | 1.61 | 1.57 | 2.74 | 3.71 | 4.99 | 1.66 | 3.40 | 0.44 | 1.82 | 3.13 | 5.02 | 6.69 | 9.70 | 11.46 | 13.45 | 13.76 | 14.38 | 15.72 |
Common Stock | n/a | n/a | n/a | 96K | 96K | 94K | 92K | 92K | 92K | 83K | 82K | 72K | 71K | 71K | 70K | 70K | 70K | 70K | 69K | 68K | 68K | 67K |
Retained Earnings | -4.81B | -4.72B | -4.53B | -4.4B | -4.22B | -4.11B | -3.96B | -3.82B | -3.69B | -3.56B | -3.39B | -3.26B | -3.1B | -2.94B | -2.78B | -2.63B | -2.38B | -2.23B | -2.07B | -1.95B | -1.88B | -1.76B |
Comprehensive Income | 10M | 10M | 1M | 8.81M | -268K | -341K | -643K | 896K | -1.1M | -431K | 647K | -2.24M | -3.1M | -3.97M | -6.57M | -10.22M | -8.91M | -6.55M | -1.4M | 54K | 232K | 56K |
Shareholders Equity | -291M | -236M | -80M | 9.16M | 151.29M | 144.25M | 255.3M | 346.83M | 432.42M | 140.26M | 275.41M | 31.71M | 129.03M | 220.48M | 352.49M | 468.83M | 678.07M | 796.42M | 922.56M | 933.67M | 972.17M | 1.05B |
Total Investments | 317M | 365M | 318M | 244.81M | 362.73M | 435.95M | 571.3M | 674.08M | 393.8M | 456.41M | 563.53M | 455.63M | 521.75M | 634M | 763.79M | 618.37M | 561.64M | 685.46M | 726.47M | 830.04M | 786.62M | 797.99M |
Add to Watchlist
Select watchlists to add or remove RARE